ONCOLINES Trademark

Trademark Overview


On Friday, October 7, 2022, a trademark application was filed for ONCOLINES with the United States Patent and Trademark Office. The USPTO has given the ONCOLINES trademark a serial number of 79355700. The federal status of this trademark filing is REGISTERED as of Tuesday, February 13, 2024. This trademark is owned by Oncolines B.V.. The ONCOLINES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research for medical purposes in the area of cancerous diseases; providing laboratory research in the field of gene expression, namely, cancer biology; medical research services, namely, performing proliferation assays in vitro with cell ines; scientific research services relating to testing of substances, drugs and pharmaceutical preparations in vitro with cell lines for scientific research purposes; scientific research services, namely, performing protein kinase assays; scientific research services relating to testing of substances, drugs and pharmaceutical preparations in protein kinase assays for scientific research purposes; scientific research services, namely, performing enzyme assays; consultancy relating to research and development in the field of medicines and pharmaceutical preparations
oncolines

General Information


Serial Number79355700
Word MarkONCOLINES
Filing DateFriday, October 7, 2022
Status700 - REGISTERED
Status DateTuesday, February 13, 2024
Registration Number7301525
Registration DateTuesday, February 13, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 28, 2023

Trademark Statements


Goods and ServicesScientific research for medical purposes in the area of cancerous diseases; providing laboratory research in the field of gene expression, namely, cancer biology; medical research services, namely, performing proliferation assays in vitro with cell ines; scientific research services relating to testing of substances, drugs and pharmaceutical preparations in vitro with cell lines for scientific research purposes; scientific research services, namely, performing protein kinase assays; scientific research services relating to testing of substances, drugs and pharmaceutical preparations in protein kinase assays for scientific research purposes; scientific research services, namely, performing enzyme assays; consultancy relating to research and development in the field of medicines and pharmaceutical preparations

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, November 20, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOncolines B.V.
Party Type30 - Original Registrant
Legal Entity Type26 - NOT AVAILABLE
AddressNL

Party NameOncolines B.V.
Party Type20 - Owner at Publication
Legal Entity Type26 - NOT AVAILABLE
AddressNL

Party NameOncolines B.V.
Party Type10 - Original Applicant
Legal Entity Type26 - NOT AVAILABLE
AddressNL

Trademark Events


Event DateEvent Description
Thursday, November 17, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Sunday, November 20, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 24, 2022APPLICATION FILING RECEIPT MAILED
Monday, July 24, 2023ASSIGNED TO EXAMINER
Tuesday, August 15, 2023NON-FINAL ACTION WRITTEN
Wednesday, August 16, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, September 5, 2023REFUSAL PROCESSED BY MPU
Tuesday, September 5, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, September 25, 2023REFUSAL PROCESSED BY IB
Friday, September 29, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 29, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, September 30, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 24, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 8, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 8, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Monday, November 27, 2023NOTIFICATION PROCESSED BY IB
Tuesday, November 28, 2023PUBLISHED FOR OPPOSITION
Tuesday, November 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 13, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, February 13, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, May 15, 2024FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, June 11, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, May 15, 2024FINAL DISPOSITION PROCESSED
Monday, May 13, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB